AFG
RMD icon

ABLE Financial Group’s ResMed RMD Stock Holding History

ABLE Financial Group’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$337K Sell
1,730
-461
-21% -$95.5K 0.06% 168
2026
Q1 		$492K Buy
2,191
+77
+4% +$19.2K 0.1% 137
2025
Q4 		$509K Sell
2,114
-134
-6% -$34.3K 0.1% 128
2025
Q3 		$615K Sell
2,248
-57
-2% -$15.6K 0.13% 112
2025
Q2 		$595K Buy
2,305
+277
+14% +$66.1K 0.14% 109
2025
Q1 		$454K Sell
2,028
-611
-23% -$143K 0.13% 110
2024
Q4 		$604K Buy
2,639
+72
+3% +$17.3K 0.18% 89
2024
Q3 		$627K Sell
2,567
-299
-10% -$66.8K 0.19% 82
2024
Q2 		$549K Buy
2,866
+715
+33% +$145K 0.2% 83
2024
Q1 		$426K Sell
2,151
-428
-17% -$78.4K 0.17% 97
2023
Q4 		$444K Sell
2,579
-197
-7% -$30.3K 0.19% 92
2023
Q3 		$410K Buy
2,776
+1,632
+143% +$295K 0.21% 88
2023
Q2 		$250K Buy
+1,144
New +$255K 0.13% 119

Other funds holding RMD

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AT
Arbejdsmarkedets Tillaegspension Hilleroed $4.6B AUM
CISOA
Capital Investment Services of America Milwaukee, Wisconsin $1.02B AUM 3.04% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.78B AUM 23.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AC
Addenda Capital Montreal, Quebec, Canada $3.68B AUM 32.88% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

ABLE Financial Group's RMD Position: Q2 2026 in Review

ABLE Financial Group reduced its ResMed (RMD) stake by 21% in Q2 2026, selling an estimated $95.5K and leaving 1,730 shares worth $337K. The position accounts for 0.06% of the portfolio, ranked #168.

ABLE Financial Group first reported a position in RMD in Q2 2023 and has held it in 13 quarters since. The position peaked at $627K in Q3 2024. 150 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • ABLE Financial Group held 1,730 shares of ResMed worth $337K as of Q2 2026.
  • ABLE Financial Group sold 461 ResMed shares in Q2 2026, an estimated $95.5K.
  • ResMed made up 0.06% of ABLE Financial Group's portfolio in Q2 2026, its #168 holding.
  • ABLE Financial Group first reported a position in ResMed in Q2 2023 and has held it in 13 quarters since.
  • ABLE Financial Group's ResMed position peaked at $627K in Q3 2024.
  • 150 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on ABLE Financial Group's 13F filing for Q2 2026, filed 22 Jul 2026.